Columbia Capital’s Kite Pharma, Inc. KITE Stock Holding History

Columbia Capital’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$851K	Buy	+14,758	New	+$621K	0.93%	34

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SFM

Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Columbia Capital's KITE Position: Q4 2014 in Review

Columbia Capital opened a new position in Kite Pharma, Inc. (KITE) in Q4 2014: 14,758 shares worth $851K. The stake represents 0.93% of the portfolio and ranks #34 among its holdings.

116 funds tracked by Wall St. Rank hold KITE as of Q4 2014.

Columbia Capital held 14,758 shares of Kite Pharma, Inc. worth $851K as of Q4 2014.
Kite Pharma, Inc. was a new Columbia Capital position in Q4 2014.
Kite Pharma, Inc. made up 0.93% of Columbia Capital's portfolio in Q4 2014, its #34 holding.
116 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.